GlaxoSmithKline Pharmaceuticals share news, announcements and annual reports
NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap
GlaxoSmithKline Pharmaceuticals Limited · Formerly Glaxo (India) · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1969 on BSE, Dec 2000 on NSE
Last close ₹2,531.40up ₹37.10 (1.49%)BSE ₹2,528.35
Share price at the NSE close on 2 Nov 2026. Previous close ₹2,494.30.
2 Nov: open ₹2,494.30, high ₹2,583.10, low ₹2,494.30
52-week range of traded prices to 2 Nov 2026
₹2,088.10Low, 12 Jun 2026₹3,120.70High, 28 Aug 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹42,883 Cr221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 18.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.25%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 50.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 56.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 67,153
GlaxoSmithKline Pharmaceuticals share news and announcements
719 announcements, routine notices left out, newest first. Page 5 of 15.
Dec 2023
7 Dec · Updates
6 Dec · Updates
6 Dec · Management
Nov 2023
23 Nov · Analysts
20 Nov · Analysts
16 Nov · Updates
9 Nov · Board meeting
9 Nov · Results
Oct 2023
31 Oct · Management
28 Oct · Updates
9 Oct · Updates
Aug 2023
24 Aug · Updates
11 Aug · Analysts
Jul 2023
26 Jul · Business
26 Jul · Board meeting
26 Jul · Results
Jun 2023
29 Jun · Board meeting
27 Jun · Analysts
21 Jun · Meeting
21 Jun · Updates
8 Jun · Analysts
May 2023
30 May · Corporate action
17 May · Dividend
17 May · Results
Apr 2023
Mar 2023
13 Mar · Analysts
Feb 2023
7 Feb · Results
Jan 2023
11 Jan · Board meeting
Dec 2022
Nov 2022
30 Nov · Meeting
22 Nov · Related Party Transaction
11 Nov · Business
Oct 2022